NCT06667453 - A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Myotonic Dystrophy 1

Interventions

DRUG

PGN-EDODM1

Administered by intravenous (IV) infusion

OTHER

Placebo

Administered by intravenous (IV) infusion

Trial Locations (6)

RECRUITING

University of Calgary, Calgary

RECRUITING

Ottawa Hospital Research Institute (OHRI), Ottawa

RECRUITING

CIUSSS du Saguenay-Lac-Saint-Jean, Chicoutimi

RECRUITING

University College London Hospitals NHS Foundation Trust, London

RECRUITING

Montreal Neurological Institute, Montreal

RECRUITING

Newcastle Upon Tyne Hospitals, Newcastle upon Tyne